MedTrace Logo

MLX/XLX ACR Expandable Lumbar Interbody Implants

NCT04420143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-12-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of thoracic and/or lumbar spine surgery using the MLX and XLX ACR interbody implants as measured by reported complications, radiographic outcomes, and clinical patient outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of the MLX and XLX ACR interbody implants.

Conditions

  • Degenerative Disc Disease
  • Spondylolisthesis
  • Degenerative Scoliosis

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kyle Malone, MS · NuVasive

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-27
Primary Completion
2020-10-23
Completion
2020-10-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04420143 on ClinicalTrials.gov